top of page

Impacting Sepsis Outcomes Using MALDI-TOF: FDA-Cleared Application for Rapid Microbial ID Direct from Positive Blood

Wed, Feb 23

|

Webiar

During this webinar we will present the Lahey four-year journey of using the MBT Sepsityper® solution for the rapid identification (ID) of microorganisms direct from positive blood culture (PBC). The focus will be on the recent implementation of the MBT Sepsityper Kit US IVD, the only FDA cleared...

Registration is closed
See other events
Impacting Sepsis Outcomes Using MALDI-TOF: FDA-Cleared Application for Rapid Microbial ID Direct from Positive Blood
Impacting Sepsis Outcomes Using MALDI-TOF: FDA-Cleared Application for Rapid Microbial ID Direct from Positive Blood

Time & Location

Feb 23, 2022, 9:00 AM PST

Webiar

Share this event

bottom of page